News

Newsmogrifydigital2021-10-05T08:57:28+00:00

FEATURED

CONTENT

Mogrify Strengthens Executive Leadership Team with the Appointment of Louise Modis as Chief Scientific Officer

Dr. Louise Modis has been appointed to the Company’s executive leadership team as Chief Scientific Offier.

Louise is an accomplished scientific leader in therapeutic discovery and development, and holds considerable experience in the progression of pre-clinical and clinical-stage assets, across various modalities and therapeutic areas.

In her new role, Louise will lead the advancement of the Company’s internal programs to help address high unmet clinical need in ophthalmology, immuno-oncology and other disease areas.

Latest

NEWS

Mogrify Strengthens Executive Leadership Team with the Appointment of Louise Modis as Chief Scientific Officer

Mark Cavanagh2021-10-05T08:00:13+00:005th October 2021|

Mogrify completes Series A financing totaling $33 million USD

Mark Cavanagh2021-05-04T09:19:54+00:004th May 2021|

Mogrify wins Hewitsons Award for Innovation in Business and Price Bailey Award for Business of the Year at CambridgeshireLive Business Excellence Awards 2020

Mark Cavanagh2021-03-26T09:07:03+00:0026th March 2021|

Mogrify enters research collaboration with the MRC Laboratory of Molecular Biology

Mark Cavanagh2021-01-13T14:15:26+00:0011th January 2021|

Mogrify solidifies IP position surrounding core technology and expands platform algorithm to enhance cell conversion

Mark Cavanagh2020-12-17T09:06:25+00:0017th December 2020|

Mogrify appoints Profs. Christine Mummery, Graziella Pellegrini and Giulio Cossu to Scientific Advisory Board

Mark Cavanagh2020-11-02T09:13:23+00:002nd November 2020|

Load More Posts

Latest

Resources

VIEW ALL RESOURCES

VIEW ALL MEDIA FEATURES

VIEW ALL EVENTS

Follow Us On

Social Media